Huons Global Co., Ltd. Logo

Huons Global Co., Ltd.

Develops pharmaceuticals, medical devices, cosmetics, and health foods for the global market.

084110 | KO

Overview

Corporate Details

ISIN(s):
KR7084110006
LEI:
Country:
South Korea
Address:
경기도 성남시 수정구 창업로 17 판교 아이스퀘어 A동 9층, 성남시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Huons Global Co., Ltd. is a holding company for a total healthcare group focused on providing solutions for human health. The company's core business encompasses the research, development, manufacturing, and sale of pharmaceutical products, medical devices, cosmetics, and health-functional food components. With a history dating back to 1965, the group has notable achievements, including the development of local anesthetics. Huons Global prioritizes expanding its research and development capabilities to find new growth engines and is actively advancing its presence in the global healthcare market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 2.0 MB
2025-08-06 00:00
Notice of Dividend Amount
중간(분기)배당을위한주주명부폐쇄(기준일)결정(자회사의 주요경영사항)
Korean 6.3 KB
2025-08-06 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정(자회사의 주요경영사항) (중간배당)
Korean 9.6 KB
2025-08-06 00:00
Notice of Dividend Amount
중간(분기)배당을위한주주명부폐쇄(기준일)결정
Korean 5.6 KB
2025-08-06 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정 (중간배당)
Korean 8.8 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.6 MB
2025-04-07 00:00
Notice of Dividend Amount
[기재정정]현금ㆍ현물배당결정(자회사의 주요경영사항)
Korean 14.7 KB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 32.7 KB
2025-03-28 00:00
Board/Management Information
대표이사변경
Korean 10.5 KB
2025-03-28 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 11.4 KB
2025-03-20 00:00
Annual Report
사업보고서 (2024.12)
Korean 2.8 MB
2025-03-19 00:00
Audit Report / Information
감사보고서제출
Korean 25.8 KB
2025-03-17 00:00
Audit Report / Information
감사보고서제출(자회사의 주요경영사항)
Korean 26.8 KB
2025-03-14 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 105.4 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의
Korean 25.1 KB

Automate Your Workflow. Get a real-time feed of all Huons Global Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Huons Global Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Huons Global Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

IN8BIO, INC. Logo
Clinical-stage biopharma developing gamma-delta T cell therapies for solid & hematological tumors.
United States of America
INAB
Develops targeted dermatology & oncology therapies using unique formulation & delivery technologies.
United Kingdom
INC
INCYTE CORP Logo
Develops proprietary therapeutics for serious unmet needs in oncology and inflammation.
United States of America
INCY
Indaptus Therapeutics, Inc. Logo
Develops immunotherapies using engineered bacteria to treat cancer and viral infections.
United States of America
INDP
Indivior PLC Logo
Develops pharmaceuticals for opioid use disorder, addiction, and serious mental illnesses.
United Kingdom
INDV
Infant Bacterial Therapeutics Logo
Develops live bacterial medicines to prevent rare, severe gut diseases in premature infants.
Sweden
IBT
InflaRx N.V. Logo
Develops complement system inhibitors for severe inflammatory diseases and immuno-dermatology.
United States of America
IFRX
Inhibikase Therapeutics, Inc. Logo
Develops kinase inhibitors to treat neurodegenerative diseases like Parkinson's.
United States of America
IKT
Inhibrx Biosciences, Inc. Logo
Clinical-stage biopharma developing novel biologic therapies for life-threatening cancers.
United States of America
INBX
InMed Pharmaceuticals Inc. Logo
Develops cannabinoid drugs for unmet medical needs and supplies rare cannabinoids for B2B wellness.
United States of America
INM

Talk to a Data Expert

Have a question? We'll get back to you promptly.